50.37000 USD
0.19
0.38%
Last update Dec 15, 3:59 PM EST
Post-market
Day range
49.55000
50.65500
Previous close
50.18000
Open
49.96000
Access this stock data via API
Subscribe
Novo Nordisk A/S Sponsored ADR
50.37
0.19
0.38%

Financials

Income statement

Fundamentals currency is DKK
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 11.8B 12.1B 12.3B 13.5B
Cost of revenue 2.8B 2.0B 2.0B 2.0B
Gross profit 9.0B 10.1B 10.3B 11.4B
Operating expense
Research & development 2.4B 1.8B 1.6B 2.2B
Selling general and admin 2.8B 3.0B 2.5B 3.2B
Other operating expenses 18.4M 3.6M -2.2M 289.2M
Operating income 3.7B 5.3B 6.1B 5.8B
Non operating interest income
Income 288.5M 835.6M 538.5M -70.3M
Expense 779.6M 815.0M -96.4M
Other income expense
Pretax income 4.0B 5.3B 5.8B 5.6B
Tax provision 866.5M 1.1B 1.3B 1.2B
Net income 3.1B 4.2B 4.6B 4.4B
Basic EPS 4.5 6.0 6.5
Diluted EPS 4.5 6.0 6.5
Basic average shares 698.7M 699.2M 698.1M
Diluted average shares 699.2M 699.2M 699.2M
EBITDA 4.9B 6.9B 7.2B 5.5B
Net income from continuing op. 3.1B 4.2B 4.6B 4.4B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 23 minutes

18:37
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).